These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1195563)

  • 1. Effect of 25-hydroxycholecalciferol on calcium absorption in chronic renal disease.
    Rutherford WE; Blondin J; Hruska K; Kopelman R; Klahr S; Slatopolsky E
    Kidney Int; 1975 Nov; 8(5):320-4. PubMed ID: 1195563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dihydroxylated metabolites of vitamin D3 on calcium absorption in uraemic man.
    Muirhead N; Catto GR; Gvozdanovic S; Gvozdanovic D; Edward N
    Clin Sci (Lond); 1981 Dec; 61(6):723-7. PubMed ID: 6975197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure.
    Colodro IH; Brickman AS; Coburn JW; Osborn TW; Norman AW
    Metabolism; 1978 Jun; 27(6):745-53. PubMed ID: 651659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; de Luca HF
    Proc Eur Dial Transplant Assoc; 1976; 12():227-36. PubMed ID: 935115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1alpha-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 3 deoxy-1alpha-hydroxycholecalciferol, 24R, 25-dihydroxycholecalciferol and successful renal transplantation on calcium absorption in haemodialysis patients.
    Pierides AM; Aljama P; Kerr DN; Scott M; Norman AW
    Nephron; 1978; 20(4):203-11. PubMed ID: 345140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
    Wong RG; Norman AW; Reddy CR; Coburn JW
    J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.
    Vergne-Marini P; Parker TF; Pak CY; Hull AR; DeLuca HF; Fordtran JS
    J Clin Invest; 1976 Apr; 57(4):861-6. PubMed ID: 947957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha-hydroxycholecalciferol: a promising therapeutic approach for renal osteodystrophy.
    Gotloib L; Mines M; Mazur Y; Sklan D; Garmizo AL; Jancu J; Israeli M; Malul M
    Isr J Med Sci; 1978 Jul; 14(7):731-5. PubMed ID: 681163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1 alpha-hydroxylated metabolites of cholecalciferol on intestinal radiocalcium absorption in goats.
    Hove K
    Br J Nutr; 1984 Jan; 51(1):157-64. PubMed ID: 6546296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 1-alpha-hydroxycholecalciferol (1 alpha-OH/D3) and 24,25-dihydroxycholecalciferol (24, 25-OH)2D3) on calcium and phosphorus metabolism in chronic renal failure].
    Galus K; Szymendera J; Jelińska S; Schabowska M; Jelonek A
    Pol Arch Med Wewn; 1979 Feb; 61(2):105-12. PubMed ID: 440977
    [No Abstract]   [Full Text] [Related]  

  • 14. 1alpha-hydroxycholecalciferol in the treatment of hypoparathyroidism.
    Jorgensen H; Vogt JH
    Acta Med Scand; 1977 Jan; 201(1-2):3-7. PubMed ID: 835368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
    Binswanger U; Schiffl H; Huggler M; Becker C
    Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 17. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
    Chan JC; Oldham SB; Holick MF; DeLuca HF
    JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deterioration of renal function in non-dialytic uraemics caused by 1 alpha (OH)D3 which was not attributable to hypercalcaemia.
    Yoshiyama N; Akiba T; Matsui N; Iwamoto H; Ogura M; Nakagawa S; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1980; 17():569-74. PubMed ID: 7243799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man.
    Brickman AS; Coburn JW; Norman AW
    N Engl J Med; 1972 Nov; 287(18):891-5. PubMed ID: 4342432
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of 1 alpha-hydroxycholecalciferol therapy in chronic hemodialysis patients.
    Rubinger D; Friedlaender MM; Bernheim J; Shachner E; Ronen M; Czaczkes WJ
    Isr J Med Sci; 1982 Oct; 18(10):1019-26. PubMed ID: 7174269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.